Large-Scale Trial Of Merck's Experimental HIV Vaccine To Begin In South Africa

... A large-scale trial of Merck's experimental HIV vaccine, called MRKAd5 HIV-1, is set to begin in South Africa, the Wall Street Journal reports (Wall Street Journal, 2/9). The trial -- announced on Thursday and to be conducted by the South African AIDS Vaccine Initiative and the HIV Vaccine Trials Network -- is supported by the National Institute of Allergy and Infectious Diseases. [click link for full article] ...